Medication management of type 2 diabetes in residential aged care
Jacquelina Stasinopoulos, J Simon Bell, Jo-Anne Manski-Nankervis, Michelle Hogan, Peter Jenkin, Janet K Sluggett
AUSTRALIAN JOURNAL OF GENERAL PRACTICE | ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS | Published : 2018
BACKGROUND: Medication management of type 2 diabetes mellitus (T2DM) in residential aged care facilities (RACFs) requires consideration of the residents’ goals of care and susceptibility to adverse drug events (ADEs). OBJECTIVE: The aim of this article is to review best practice medication management for residents diagnosed with T2DM. DISCUSSION: Management of T2DM in RACFs is often focused on maintaining residents’ quality of life rather than intensive glycaemic management to reduce chronic complications, because the risks of intensive glycaemic management typically outweigh the potential benefits. Australian RACF guidelines recommend individualised glycated haemoglobin targets of 7–8.5% (5..View full abstract
JS is a recipient of the Cyril Tonkin Scholarship for PhD research at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.